Home/Inomagen Therapeutics/Robert Moen, MD, Ph.D.
RM

Robert Moen, MD, Ph.D.

VP, Research & Development

Inomagen Therapeutics

Inomagen Therapeutics Pipeline

DrugIndicationPhase
Non-viral gene therapy for Atrial FibrillationAtrial FibrillationPre-clinical